Global  

Merck receives FDA approval for Ebola vaccine

Reuters Friday, 20 December 2019
The U.S. Food and Drug Administration said on Thursday it approved drugmaker Merck & Co's Ebola vaccine Ervebo, making it the first FDA-authorised vaccine against the deadly virus.
0
shares
ShareTweetSavePostSend
 
Video Credit: Veuer - Published
News video: Ebola Vaccine Gets U.S. Approval from FDA

Ebola Vaccine Gets U.S. Approval from FDA 00:45

In a first, a vaccine that prevents Ebola has been given approval from the U.S. Food and Drug Administration. Veuer’s Justin Kircher has more.

💡 One News Page Knowledge: Other News Mentions

Food and Drug Administration Food and Drug Administration Agency of the United States Department of Health and Human Services

Covid-19 News: Live Updates

President Trump said the White House “may or may not” approve new F.D.A. guidelines that would toughen the process for approving a coronavirus vaccine.
NYTimes.com

Trump May Reject Tougher F.D.A. Vaccine Standards, Calling Them ‘Political’

In suggesting he might reject tougher guidelines, President Trump once again undermined efforts by government scientists to bolster public confidence in their..
NYTimes.com

Samsung’s Galaxy Watch 3 and Active 2 can now take EKG readings in the US

Dan Seifert / The Verge

Samsung got US FDA clearance for its electrocardiogram (EKG) monitoring app in August, but today the functionality is finally..

The Verge
J&J launches final study of COVID-19 vaccine [Video]

J&J launches final study of COVID-19 vaccine

The drug giant said it would begin a stage three trial of a single-shot vaccine, which could prove easier to administer than rivals that require two inoculations. This report produced by Zachary Goelman.

Credit: Reuters - Politics    Duration: 01:09Published

F.D.A. to Release Stricter Guidelines for Emergency Vaccine Authorization

The new guidelines underscore the fact that a vaccine is highly unlikely before the election.
NYTimes.com

You Might Like


Related news from verified sources

New Pneumococcal Vaccine from Serum Institute of India Achieves WHO Prequalification

New Pneumococcal Vaccine from Serum Institute of India Achieves WHO Prequalification
PNEUMOSIL®, a vaccine against a leading cause of deadly childhood pneumonia - the pneumococcus bacterium - has achieved prequalification by the World Health...
NewsVoir

A shot of confusion for parents

A shot of confusion for parents
The first 18 months since her daughter, Drea's birth, Kandivli resident Mansi Sheth would dread the paediatrician visits to Princess Street in Marine Lines. It...
Mid-Day

Why Isn’t There A Vaccine For Staph?

Staph bacteria, the leading cause of potentially dangerous skin infections, are most feared for the drug-resistant strains that have become a serious threat to...
Eurasia Review


Tweets about this